Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-27.77	49.78	-68.92
Graham Fair Price	16.08	2617.71	2255.05
PEG	10.19	-0.04	0.03
Price/Book	5.40	0.50	0.47
Price/Cash Flow	314.41	-55.37	13.36
Prices/Earnings	-21.21	8.65	-10.98
Price/Sales	-3.40	3.74	3.88
Price/FCF	314.41	-55.37	13.36
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	98.72	0.15	0.08
Operating Margin	-86.97	0.01	-0.10
ROA	31.48	0.01	< 0.005
ROE	-0.01	0.01	33.76
ROIC	< 0.005	< 0.005	-84.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	-0.10	35.08
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.12	1.14	-46.04
EPS QOQ	-3.28	2.34	-28.49
FCF QOQ	0.94	-1.26	32.84
Revenue QOQ	-0.12	0.10	-21.12
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	94.28	98.38	4.34
Days Sales Outstanding (DSO)	63.27	71.13	12.42
Inventory Turnover	0.95	0.91	-4.16
Debt/Capitalization	< 0.005	< 0.005	3.23
Quick Ratio	5.92	5.46	-7.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4594.02	4610.96	0.37
Cash	1556.80	1583.81	1.73
Capex	-13.55	-3.70	72.70
Free Cash Flow	161.65	-41.27	-74.47
Revenue	557.19	610.21	9.52
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	7.60	7.01	-7.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.34	-12.69	-34.37
Naive Interpretation	Member

06 - Financial Health · Bad

Rating